This statistic depicts the number of new clinical trials for type 2 diabetes in the U.S. as of September 2018, by type and phase. As of that time, among phase I clinical trials for diabetes, 18 were for novel chemicals with new mechanisms of action.
Clinical pipeline for type 2 diabetes drugs in the U.S. as of 2018, by type and phase
Characteristic
Novel chemical + new MOA
Novel chemical + old MOA
Repurposed or reformulated
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Biotechnology Innovation Organization. (February 26, 2019). Clinical pipeline for type 2 diabetes drugs in the U.S. as of 2018, by type and phase [Graph]. In Statista. Retrieved September 10, 2024, from https://www.statista.com/statistics/992038/type-2-diabetes-clinical-pipeline-by-type-and-phase-us/
Biotechnology Innovation Organization. "Clinical pipeline for type 2 diabetes drugs in the U.S. as of 2018, by type and phase." Chart. February 26, 2019. Statista. Accessed September 10, 2024. https://www.statista.com/statistics/992038/type-2-diabetes-clinical-pipeline-by-type-and-phase-us/
Biotechnology Innovation Organization. (2019). Clinical pipeline for type 2 diabetes drugs in the U.S. as of 2018, by type and phase. Statista. Statista Inc.. Accessed: September 10, 2024. https://www.statista.com/statistics/992038/type-2-diabetes-clinical-pipeline-by-type-and-phase-us/
Biotechnology Innovation Organization. "Clinical Pipeline for Type 2 Diabetes Drugs in The U.S. as of 2018, by Type and Phase." Statista, Statista Inc., 26 Feb 2019, https://www.statista.com/statistics/992038/type-2-diabetes-clinical-pipeline-by-type-and-phase-us/
Biotechnology Innovation Organization, Clinical pipeline for type 2 diabetes drugs in the U.S. as of 2018, by type and phase Statista, https://www.statista.com/statistics/992038/type-2-diabetes-clinical-pipeline-by-type-and-phase-us/ (last visited September 10, 2024)
Clinical pipeline for type 2 diabetes drugs in the U.S. as of 2018, by type and phase [Graph], Biotechnology Innovation Organization, February 26, 2019. [Online]. Available: https://www.statista.com/statistics/992038/type-2-diabetes-clinical-pipeline-by-type-and-phase-us/